Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis
Authors:
Open Access
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 13 (4) , 342-348
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?Journal of Neurology, Neurosurgery & Psychiatry, 2010
- Disclosure ofAPOEGenotype for Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2009
- Long-term outcome of presymptomatic testing in Huntington diseaseEuropean Journal of Human Genetics, 2008
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisThe Lancet Neurology, 2008
- Living at Risk: Concealing Risk and Preserving Hope in Huntington DiseaseJournal of Genetic Counseling, 2007
- EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relativesEuropean Journal of Neurology, 2005
- Predictive Genetic Test Decisions for Huntington’s Disease: Elucidating the Test/No-test DichotomyJournal of Health Psychology, 2005
- Redefinition: Coping with normal results from predictive gene testing for neurodegenerative disordersResearch in Nursing & Health, 2000
- Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.Journal of Medical Genetics, 1995
- Predictive testing for huntington disease: A psychologist's viewAmerican Journal of Medical Genetics, 1994